GNAI2 encodes a G-protein implicated in an adenylate-cyclase-containing signaling pathway which, therefore, performs inhibitory activity in CML cells. This evidence concerns the gene GNAI2 and chronic myelogenous leukemia, BCR-ABL1 positive.